Vincerx Pharma, Inc.

As of June 6, 2025, the market trend is mildly bearish, influenced by daily moving averages and mixed signals from weekly and monthly indicators.

Vincerx Pharma, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $5 million and a market cap of $0.27 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -1,354.79%.

As of Jun 18, Vincerx Pharma, Inc. has a market capitalization of 0.27 million, classifying it as a Micro Cap company, with net sales of 0.00 million and a net profit of -22.64 million over the latest four quarters. The company reported shareholder's funds of 2.72 million and total assets of 8.01 million as of Dec 24.